首页> 外文期刊>Journal of intensive care medicine >Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years
【24h】

Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years

机译:相关的中央线相关的血流感染与用于中央静脉导管的新型镀银敷料并保持6年来相关

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To assess a novel silver-plated dressing (SD) for central venous catheters in comparison to chlorhexidine gluconate-impregnated sponge (CHGIS) dressings in preventing central line-associated bloodstream infections (CLABSIs) in adult intensive care unit (ICU) patients. Design: Retrospective cohort study. Setting: Tampa General Hospital, an academic medical tertiary care center. Patients: All adult ICU patients of an academic medical tertiary care center from January 2009 to December 2010. Measurements and Main Results: A total of 3189 patient records were studied from 7 different ICUs during the 2-year period. Patients received either CHGIS dressings (January 2009-December 2009) or SDs (January 2010-December 2010). Primary outcomes measured were CLABSI rates per 1000 catheter days and ICU length of stay. There were 30 696 catheter days with CHGIS dressings and 31 319 catheter days with SDs. There was a statistically significant decrease in the rate of CLABSI per 1000 catheter days in the SD group, from 2.38 to 1.28 (P = .001), with an absolute risk reduction of 1.1. There was a significantly lower incidence in the rate of CLABSI per 1000 catheter days in the SD group (incidence rate ratio [IRR] = 0.54, 95% confidence interval [CI]: 0.36-0.80). The relative risk of CLABSI in the SD group was 0.502 (95% CI: 0.340-0.730; P < .001). If SDs are used on all catheters, the decreased rate of CLABSIs observed would calculate to a cost savings of US$4070 to US$39 600 per 1000 catheter days. After successful implementation of the SD, we observed significant reductions in CLABSI rates and a sustained reduction in the subsequent 6 years. Conclusion: Use of SDs is associated with a significant decrease in CLABSI rates in adult ICU patients compared to CHGIS dressings, with an estimated cost savings of US$4070 to US$39 600 per 1000 catheter days.
机译:目的:评估中央静脉导管的新型镀银敷料(SD),与氯己定牙氨酸浸渍的海绵(CHGIS)敷料相比,在预防成人重症监护病房(ICU)患者中的中央线相关血流感染(Clabsis)。设计:回顾性队列研究。环境:坦帕综合医院,学术医院医院。患者:2009年1月至2010年12月的学术医学三级护理中心的所有成年ICU患者。测量和主要结果:在2年期间,共有3189名患者记录从7个不同的ice。患者接受了CHGIS敷料(2009年1月至2009年1月)或SDS(2010年1月至2010年12月)。测量的主要结果是每1000个导尿管天和ICU的钙率率。有30 696个导管含有Chgis敷料和319 319个导管天,SDS。 SD组中每1000个导管天的Clabsi率的统计学显着降低,从2.38到1.28(p = .001),绝对的风险降低1.1。 SD组中每1000个导管天的Clabsi的速率显着降低(发生率比率[IRR] = 0.54,95%置信区间[CI]:0.36-0.80)。 SD组中Clabsi的相对风险为0.502(95%CI:0.340-0.730; P <.001)。如果在所有导管上使用SDS,则观察到的Clabsis降低将计算到每1000个导管日为4070美元至39美元的成本节省。在成功实施SD之后,我们观察到在连锁症率的重大减少和随后的6年持续减少。结论:与Chgis敷料相比,使用SDS的使用与成人ICU患者中的Clabsi率显着降低有关,估计成本节省40.70美元至每1000导管日为39美元600美元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号